Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Gleiter

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Pharmacology|December 1, 1996
Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosineC H Gleiter, S Freudenthaler, U Delabar, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?S Freudenthaler, P Benöhr, A Grenz, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 11, 2008
Psoriasis aggravation and metoprolol treatment -- a prospective observational case studyR Fux, K Mörike, A M T Pröhmer, et al.
Pharmacoepidemiology and Drug Safety|April 20, 2007
Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysisM Ufer, S A Meyer, O Junge, et al.
Intensive Care Medicine|February 8, 2000
Kinetics and characteristics of an acute phase response following cardiac arrestM Oppert, C H Gleiter, C Müller, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 13, 2007
In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MSB Kammerer, H Scheible, G Zurek, et al.
Deutsche Medizinische Wochenschrift (1946)|November 29, 2002
["Off-label" prescribing of drugs in the ambulatory care of children and adolescents]R Bücheler, C Meisner, B Kalchthaler, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's diseaseK Dilger, M Alberer, A Busch, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Role of cytochrome P4502D6 in the metabolism of brofaromine. A new selective MAO-A inhibitorN Feifel, K Kucher, L Fuchs, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2006
Effect of endothelin-1 on erythropoietin production in a rat model under normoxia and functional carbon monoxide-induced hypoxiaA Grenz, J Klein, C Köhle, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|December 1, 1996
Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosineC H Gleiter, S Freudenthaler, U Delabar, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?S Freudenthaler, P Benöhr, A Grenz, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 11, 2008
Psoriasis aggravation and metoprolol treatment -- a prospective observational case studyR Fux, K Mörike, A M T Pröhmer, et al.
Pharmacoepidemiology and Drug Safety|April 20, 2007
Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysisM Ufer, S A Meyer, O Junge, et al.
Intensive Care Medicine|February 8, 2000
Kinetics and characteristics of an acute phase response following cardiac arrestM Oppert, C H Gleiter, C Müller, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 13, 2007
In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MSB Kammerer, H Scheible, G Zurek, et al.
Deutsche Medizinische Wochenschrift (1946)|November 29, 2002
["Off-label" prescribing of drugs in the ambulatory care of children and adolescents]R Bücheler, C Meisner, B Kalchthaler, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's diseaseK Dilger, M Alberer, A Busch, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Role of cytochrome P4502D6 in the metabolism of brofaromine. A new selective MAO-A inhibitorN Feifel, K Kucher, L Fuchs, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2006
Effect of endothelin-1 on erythropoietin production in a rat model under normoxia and functional carbon monoxide-induced hypoxiaA Grenz, J Klein, C Köhle, et al.
Pageof 11